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PRELIMINARY AND SHORT REPORT
TREATMENT OF PSORIASIS WITH LYSINE
LAWEENCB C. GOLDBERG, M.D.
Cincinnali, Ohio
If one believes that psoriasis is caused by
a metabolic error, then all channels should be in-
vestigated. For the past twenty or more years
many investigators and clinicians have been
favoring a defective fat metabolism to give the
hidden answer, but this theory has not yielded
significant results.
Because defective amino acid utilization might
possibly be a factor in psoriases, the administra-
tion of at least one amino acid to psoriatics was
considered. In April, 1956, lysine*, an essential
amino acid, was made available to me. Since that
time, 46 patients with psoriasis vulgaris have re-
ceived an average of 100 mgms. of lysine
per kilogram of body weight daily. Each was
treated for three months. This medication in the
form of 1-lysine monochloride is a white crystalline
material that resembles ordinary table salt. It
was made into one gram tablets, and the patients
took two tablets three times a day. There were
no untoward reactions since this amount of medi-
cation was well below a toxic dose. An occasional
patient complained of some gastric fullness after
they had taken the tablets for about six weeks.
This study was terminated in September 1957, at
which time it was determined that not one patient
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* Lysine was supplied as l-lysine monochloride,by the E. I. DuPont DeNemours & Co. The trade
name of the medication is Darvyl.
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on lysine medication had shown any improvement
while taking this essential amino acid.
COMMENT
The fact that not one patient improved under
this therapy should not be too discouraging. There
are still seven associated amino acids besides other
non-essential amino acids, peptides and polypep-
tides that can yet be investigated. This approach
is all the more hopeful since Flesch and Esoda (1)
have reported that psoriatic scales have a low free
amino nitrogen, and a high sulfhydryl dontent.
They advanced the theory that psoriasis might be
a disease of abnormal or incomplete cellular de-
composition and abnormal utilization of amino
acids for keratin synthesis.
CONCLUSION
1-Lysine monochloride, an essential amino acid,
was given to 46 patients with psoriasis vulgaris for
three month intervals of observation in a dosage
of six grams daily. No improvement in the
psoriasis was noted in any of the patients
so treated. It is hoped that, if psoriasis is an error
of metabolism caused by the amino acids or their
derivatives, this negative report will not be a
deterrent to further investigation.
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